                               SEQUENCE LISTING

<110> THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
 
<120> HYDROGEL FOR ENGINEERED IMMUNE RESPONSE TO D-CHIRALITY PEPTIDES

<130> 30435.313-WO-U1

<140> PCT/US2017/026798
<141> 2017-04-10

<150> 62/320,309
<151> 2016-04-08

<160> 10    

<170> PatentIn version 3.5

<210> 1
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 1
Phe Lys Gly Gly Glu Arg Cys 
1               5           


<210> 2
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 2
Asn Gln Glu Gln Val Ser Pro Leu 
1               5               


<210> 3
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 3
Asn Gln Glu Gln Val Ser Pro Leu Arg Gly Asp Ser Pro Gly 
1               5                   10                  


<210> 4

<400> 4
000


<210> 5
<211> 5
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 5
Ile Lys Val Ala Val 
1               5   


<210> 6
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<220>
<221> MOD_RES
<222> (7)..(7)
<223> D-Gln

<220>
<221> MOD_RES 
<222> (9)..(9)
<223> D-Ile

<220>
<221> MOD_RES 
<222> (10)..(10)
<223> D-Trp

<400> 6
Gly Cys Arg Asp Gly Pro Gln Gly Ile Trp Gly Gln Asp Arg Cys Gly 
1               5                   10                  15      


<210> 7
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 7
Arg Gly Asp Ser Pro Gly Glu Arg Cys Gly 
1               5                   10  


<210> 8
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 8
Gly Cys Arg Asp Gly Pro Gln Gly Ile Trp Gly Gln Asp Arg Cys Gly 
1               5                   10                  15      


<210> 9
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 9
Phe Lys Gly Gly Glu Arg Cys Gly 
1               5               


<210> 10
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 10
Asn Gln Glu Gln Val Ser Pro Leu Gly Gly Glu Arg Cys Gly 
1               5                   10                  


